Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Longitudinal Assessment of Multiple Immunological and Inflammatory Parameters during Successful DAA Therapy in HCV Monoinfected and HIV/HCV Coinfected Subjects.
Zuccalà P, Latronico T, Marocco R, Savinelli S, Vita S, Mengoni F, Tieghi T, Borgo C, Kertusha B, Carraro A, D'Ettorre G, Vullo V, Mastroianni CM, Liuzzi GM, Lichtner M. Zuccalà P, et al. Int J Mol Sci. 2022 Oct 8;23(19):11936. doi: 10.3390/ijms231911936. Int J Mol Sci. 2022. PMID: 36233234 Free PMC article.
Molecular mechanisms of liver fibrosis in HIV/HCV coinfection.
Mastroianni CM, Lichtner M, Mascia C, Zuccalà P, Vullo V. Mastroianni CM, et al. Among authors: zuccala p. Int J Mol Sci. 2014 May 26;15(6):9184-208. doi: 10.3390/ijms15069184. Int J Mol Sci. 2014. PMID: 24865485 Free PMC article. Review.
Liver Fibrosis in HCV Monoinfected and HIV/HCV Coinfected Patients: Dysregulation of Matrix Metalloproteinases (MMPs) and Their Tissue Inhibitors TIMPs and Effect of HCV Protease Inhibitors.
Latronico T, Mascia C, Pati I, Zuccala P, Mengoni F, Marocco R, Tieghi T, Belvisi V, Lichtner M, Vullo V, Mastroianni CM, Liuzzi GM. Latronico T, et al. Among authors: zuccala p. Int J Mol Sci. 2016 Mar 26;17(4):455. doi: 10.3390/ijms17040455. Int J Mol Sci. 2016. PMID: 27023536 Free PMC article.
Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection.
Mascia C, Lichtner M, Zuccalà P, Vita S, Tieghi T, Marocco R, Savinelli S, Rossi R, Iannetta M, Campagna M, Schiavone F, Mengoni F, Russo G, Mastroianni CM, Vullo V. Mascia C, et al. Among authors: zuccala p. Clin Res Hepatol Gastroenterol. 2017 Dec;41(6):644-655. doi: 10.1016/j.clinre.2017.04.007. Epub 2017 May 31. Clin Res Hepatol Gastroenterol. 2017. PMID: 28578937
Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon.
Mascia C, Vita S, Zuccalà P, Marocco R, Tieghi T, Savinelli S, Rossi R, Iannetta M, Pozzetto I, Furlan C, Mengoni F, Mastroianni CM, Vullo V, Lichtner M. Mascia C, et al. Among authors: zuccala p. PLoS One. 2017 Jun 21;12(6):e0179400. doi: 10.1371/journal.pone.0179400. eCollection 2017. PLoS One. 2017. PMID: 28636655 Free PMC article.
Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters.
Iannetta M, Savinelli S, Rossi R, Mascia C, Marocco R, Vita S, Zuccalà P, Zingaropoli MA, Mengoni F, Massetti AP, Falciano M, d'Ettorre G, Ciardi MR, Mastroianni CM, Vullo V, Lichtner M. Iannetta M, et al. Among authors: zuccala p. Immunobiology. 2019 Mar;224(2):231-241. doi: 10.1016/j.imbio.2018.11.011. Epub 2018 Nov 28. Immunobiology. 2019. PMID: 30522891
Impact of IFN-Free and IFN-Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan-DC, and Activated T Lymphocyte Dynamics during HCV Infection.
Vita S, Zuccalà P, Savinelli S, Mascia C, Rossi R, Schiavone F, Marocco R, Tieghi T, Iannetta M, Nijhawan P, Zingaropoli MA, d'Ettore G, Vullo V, Mastroianni CM, Lichtner M. Vita S, et al. Among authors: zuccala p. J Immunol Res. 2020 Mar 16;2020:2781350. doi: 10.1155/2020/2781350. eCollection 2020. J Immunol Res. 2020. PMID: 32258171 Free PMC article.
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II).
Maddaloni E, D'Onofrio L, Alessandri F, Mignogna C, Leto G, Pascarella G, Mezzaroma I, Lichtner M, Pozzilli P, Agrò FE, Rocco M, Pugliese F, Lenzi A, Holman RR, Mastroianni CM, Buzzetti R; CoViDiab Study Group. Maddaloni E, et al. Cardiovasc Diabetol. 2020 Oct 1;19(1):164. doi: 10.1186/s12933-020-01140-2. Cardiovasc Diabetol. 2020. PMID: 33004045 Free PMC article.
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9. J Transl Med. 2020. PMID: 33087150 Free PMC article. Clinical Trial.
Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia.
Zingaropoli MA, Nijhawan P, Carraro A, Pasculli P, Zuccalà P, Perri V, Marocco R, Kertusha B, Siccardi G, Del Borgo C, Curtolo A, Ajassa C, Iannetta M, Ciardi MR, Mastroianni CM, Lichtner M. Zingaropoli MA, et al. Among authors: zuccala p. Front Immunol. 2021 Feb 26;12:627548. doi: 10.3389/fimmu.2021.627548. eCollection 2021. Front Immunol. 2021. PMID: 33777012 Free PMC article.
24 results